BIT's 3rd International Biotechnology Congress (IBC-2019)
★ Scientific Program
Preliminary Program
Session times on those days will not be finalized until the overall program schedule is completed.

Program Tracks
(Please click each Track for detailed program information)
Opening Ceremony and Keynote Forum
Track 1: Industrial Microbiology and New Enzymes & Biocatalysis
Track 2: Novel Biomaterials
Track 3: Biomass and Bioenergy
Track 4: Environmental Biotechnology
Track 5: Green Bioprocess and Biomanufacturing

Track 5: Green Bioprocess and Biomanufacturing

Track 501: New Approaches in Upstream Bioprocessing
Time: 13:30-16:30, October 26, 2019 (Saturday); Place: Singapore

Mr. Gilles R. Gagnon, Chief Executive Officer, Ceapro Inc., Canada

Chair’s Introduction
Title: Continuous Manufacturing of Secreted Proteins in High Cell Density Perfusion Cultures of Yeast Pichia Pastors Cells
Dr. Dhinakar S. Kompala, Founder & CEO, Sudhin Biopharma Co.,USA

Title: Using Different Genome Editing Approaches on the Development of the Next-generation CHO Cell Host

Dr. Mario Pereira, Field Application Scientist, Horizon Discovery, UK


Title: New Tools for Genetic Stability Assessment of Production Cell and Its Transgene for Quality Assurance of Biotherapeutic Protein Products Prepared by Recombinant DNA technology

Dr. Edmund Ang, Senior Technical Specialist, Merck BioReliance® Services, Singapore


Title: The Use of High Pressure CO2 -facilitated pH Swings to Enhance in situ Product Recovery of Butyric Acid in a Two-Phase Partitioning Bioreactor

Dr. Eric Charles Peterson, Research Fellow, Agency for Science and Technology, Singapore


Title: Metabolic Engineering of Plant Volatiles

Dr. Sarojam Rajani, Principal Investigator, Temasek Life Sciences Laboratory, Singapore

Coffee Break

Title: Building Startups in Industrial Biotechnology

Dr. Joško Bobanovi, Partner, Sofinnova Partners, France


Title: Ceapro Inc.: Pioneering Game Changing Technologies to Process Biomaterials

Mr. Gilles R. Gagnon, Chief Executive Officer, Ceapro Inc., Canada


Speech Opportunity Available 
Abstract and Biography: 
Submit Here

Track 502: Pharmaceutical/Medical Biotechnology
Time: 13:30-17:50, October 26, 2019 (Saturday); Place: Singapore

Dr. Gottfried H. Sodeck, President, Vogelbusch GmbH, Austria

Chair’s Introduction

Title: The Challenging Definition of Naive Patient for Biological Drug Use

Dr. Francesco Scaglione, Professor, Hemato-Oncology—University of Milan , Italy

Title: Under Preparation
Dr. Ningling Wang, Managing Partner, Shanghai Representative Office of Finnegan, Henderson, Farabow, Garrett &Dunner, LLP, China

Title: Engineered Anti-PA Monoclonal Antibodies Confer Better Protection in Bacillus Anthracis pre- and post-challenge Mouse Model

Dr. Rajan P. Adhikari, Assistant Director, Integrated Biotherapeutics Inc., USA


Title: Preclinical Study of Anti-Cancer Stem Cell Drug ACT001 and Preliminary Clinical Result in GBM therapy

Dr. Yue Chen, Professor, Nankai University, China


Title: Microbial Production of 1,3-propanediol from Crude Glycerol

Dr. Gottfried H. Sodeck, President, Vogelbusch GmbH, Austria

Coffee Break

Title: Protein Binders for Insoluble Fibrin Detection and Thrombus Visualization
Dr. Petr Maly, Head of Research Group, Institute of Biotechnology of the Czech Academy of Sciences, BIOCEV Research Center, Czech Republic


Title: Development and Application of Super Flexible Heart Replicas of Congenital Heart Disease

Dr. Isao Shiraishi, Director, National Cerebral and Cardiovascular Center, Japan

Title: Personalizing New Frontiers: Asia Pacific’s Precision Medicine
Ms. Kristin Ciriello Pothier, Global Head of Life Sciences Strategy, EY Transaction Advisory Services, USA
Title: Pneumococcal Conjugate Vaccines: A Story of Medical Success
Dr. Eiman Mokaddas, Professor of Clin ical Microbiology, Kuwait University, Kuwait

Title: High Throughput Assays for the Determination of the Potency and Comparability of Biosimilars and Innovator Products

Dr. Michael G Tovey, Managing Director, Svar Life Science, France


Title:  Drug Discovery Using Automated Synthesizer & Flow Reactor and Its Social Effect in Japan

Dr. Takashi Takahashi, Professor, Yokohama University of Pharmacy, Japan


Title: Investigation of Interaction between Hsp70.14 and the RING Finger Domain of RBBP6
Dr. Paul Chukwudi Ikwegbue, University of Zululand, South Africa

Track 503: Biotechnology in Food & Agriculture
Time: 09:00-11:40, October 27, 2019 (Sunday); Place: Singapore
Dr. Igor I. Katkov, Head, Lab of the Amorphous State, Beglorod National Research University, Russia; Scientific Director, CELLTRONIX, San Diego, USA
09:00- 09:05
Chair’s Introduction

Title: Regulatory and Safety Requirements for Food Cultures

Dr. Anette Wind, Senior Principal Scientist, Chr. Hansen A/S, Denmark


Title: Valorization of Silverskin, A Coffee Roasting By-product: From Laboratorial Studies to Industrial Implementation

Dr. Maria Beatriz P. P. Oliveira, Associate, Professor with Habilitation, University of Porto, Portugal

Title:  Using Botanical Insecticides for Insect Pest Management Control

Dr. Errol Hassan, Adjunct Associate Professor, The University of Queensland, Australia


Coffee Break


Title: Perspectives on the Use of Natural Antimicrobials and Inhibitors for Food Applications: Effect of Pine Bark Extracts against Listeria monocytogenes ATCC 13932
Dr. Joana Santos, Professor, CISAS-Instituto Politécnico de Viana do Castelo, Portugal


Title: Kinetic (Hyperfast and Free of Permeable Cryoprotectants) Vitrification: A Novel Approach for Biotechnology of Husbandry Reproduction

Dr. Igor I. Katkov, Head, Lab of the Amorphous State, Beglorod National Research University, Russia; Scientific Director, CELLTRONIX, San Diego, USA


Title: International Human Biospecimen Biobanking for Precision Medicine
Dr. Olga Potapova, Founder and CEO, Cureline, Inc., Brisbane, CA, USA


Title: Genetic Manipulation of Alkaloid Biosynthesis in Plants: Use of Evolutionally Conserved Transcription Factors  

Dr. Tsubasa Shoji, Associate Professor, Nara Institute of Science and Technology, Japan


Online Registration
News Released

● The scientific program has updated
● Call for speakers, exhibitors and sponsors worldwide.
● Call for media partners and advertiser worldwide.     
● Call for paper

Hosting Organization

National Foreign Experts Databank of MOST (Dalian Branch)

Operating Organization

BIT Group Global Ltd.

Official Travel Agency

BIT World Travel Service, Inc.

BIT’s Upcoming Events
Contact Us

Add: East Area, F11, Building 1, Dalian Ascendas IT Park, 1 Hui Xian Yuan, Dalian Hi-tech Industrial Zone, LN 116025, China
Tel: 0086-411-84799609, Fax: 0086-411-84796897
Copyright © 2017-2019 BIT Congress Inc.